The present invention relates to pharmaceuticals. Specifically, the presentinvention relates to geranyl geranyl transferase inhibitor as therapeutic target fordiabetic liver injury. The present invention further relates to a particular dosageform of geranyl geranyl transferase inhibitor as hepatoprotective against diabeticliver injury.
Gurjeet Thakur, Onkar Bedi, Ekta